Literature DB >> 16107691

p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.

Jenny S L Ho1, Weili Ma, Daniel Y L Mao, Samuel Benchimol.   

Abstract

The ability of p53 to promote apoptosis and cell cycle arrest is believed to be important for its tumor suppression function. Besides activating the expression of cell cycle arrest and proapoptotic genes, p53 also represses a number of genes. Previous studies have shown an association between p53 activation and down-regulation of c-myc expression. However, the mechanism and physiological significance of p53-mediated c-myc repression remain unclear. Here, we show that c-myc is repressed in a p53-dependent manner in various mouse and human cell lines and mouse tissues. Furthermore, c-myc repression is not dependent on the expression of p21(WAF1). Abrogating the repression of c-myc by ectopic c-myc expression interferes with the ability of p53 to induce G(1) cell cycle arrest and differentiation but enhances the ability of p53 to promote apoptosis. We propose that p53-dependent cell cycle arrest is dependent not only on the transactivation of cell cycle arrest genes but also on the transrepression of c-myc. Chromatin immunoprecipitation assays indicate that p53 is bound to the c-myc promoter in vivo. We report that trichostatin A, an inhibitor of histone deacetylases, abrogates the ability of p53 to repress c-myc transcription. We also show that p53-mediated transcriptional repression of c-myc is accompanied by a decrease in the level of acetylated histone H4 at the c-myc promoter and by recruitment of the corepressor mSin3a. These data suggest that p53 represses c-myc transcription through a mechanism that involves histone deacetylation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107691      PMCID: PMC1190302          DOI: 10.1128/MCB.25.17.7423-7431.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  p53 down-regulates CHK1 through p21 and the retinoblastoma protein.

Authors:  V Gottifredi; O Karni-Schmidt; S S Shieh; C Prives
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression.

Authors:  S D'Souza; H Xin; S Walter; D Choubey
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

3.  Direct examination of histone acetylation on Myc target genes using chromatin immunoprecipitation.

Authors:  S R Eberhardy; C A D'Cunha; P J Farnham
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

4.  Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis.

Authors:  C M Eischen; D Woo; M F Roussel; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

5.  A functional wild-type p53 gene is expressed in human acute myeloid leukemia cell lines.

Authors:  T Sutcliffe; L Fu; J Abraham; H Vaziri; S Benchimol
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

6.  Myc potentiates apoptosis by stimulating Bax activity at the mitochondria.

Authors:  E L Soucie; M G Annis; J Sedivy; J Filmus; B Leber; D W Andrews; L Z Penn
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

7.  Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.

Authors:  M Murphy; J Ahn; K K Walker; W H Hoffman; R M Evans; A J Levine; D L George
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

8.  DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter.

Authors:  Selvon St Clair; Luciana Giono; Shohreh Varmeh-Ziaie; Lois Resnick-Silverman; Wen-Jun Liu; Abhilash Padi; Jayasri Dastidar; Andrea DaCosta; Melissa Mattia; James J Manfredi
Journal:  Mol Cell       Date:  2004-12-03       Impact factor: 17.970

9.  p53-dependent down-regulation of telomerase is mediated by p21waf1.

Authors:  Igor Shats; Michael Milyavsky; Xiaohu Tang; Perry Stambolsky; Neta Erez; Ran Brosh; Ira Kogan; Ilana Braunstein; Maty Tzukerman; Doron Ginsberg; Varda Rotter
Journal:  J Biol Chem       Date:  2004-09-15       Impact factor: 5.157

10.  Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells.

Authors:  K O Mitchell; W S El-Deiry
Journal:  Cell Growth Differ       Date:  1999-04
View more
  121 in total

1.  p53-Dependent induction of PVT1 and miR-1204.

Authors:  Anthony M Barsotti; Rachel Beckerman; Oleg Laptenko; Konrad Huppi; Natasha J Caplen; Carol Prives
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

2.  P53 is required for the developmental restriction in Müller glial proliferation in mouse retina.

Authors:  Yumi Ueki; Mike O Karl; Samuel Sudar; Julia Pollak; Russell J Taylor; Kati Loeffler; Matthew S Wilken; Sara Reardon; Thomas A Reh
Journal:  Glia       Date:  2012-07-06       Impact factor: 7.452

3.  GATA-1 associates with and inhibits p53.

Authors:  Cecelia D Trainor; Caroline Mas; Patrick Archambault; Paola Di Lello; James G Omichinski
Journal:  Blood       Date:  2009-05-01       Impact factor: 22.113

Review 4.  Perspectives for cancer prevention with natural compounds.

Authors:  A R M Ruhul Amin; Omer Kucuk; Fadlo R Khuri; Dong M Shin
Journal:  J Clin Oncol       Date:  2009-05-04       Impact factor: 44.544

5.  Global Inhibition with Specific Activation: How p53 and MYC Redistribute the Transcriptome in the DNA Double-Strand Break Response.

Authors:  Joshua R Porter; Brian E Fisher; Laura Baranello; Julia C Liu; Diane M Kambach; Zuqin Nie; Woo Seuk Koh; Ji Luo; Jayne M Stommel; David Levens; Eric Batchelor
Journal:  Mol Cell       Date:  2017-08-31       Impact factor: 17.970

6.  Targeted Therapy for EBV-Associated B-cell Neoplasms.

Authors:  Siddhartha Ganguly; Sudhakiranmayi Kuravi; Satyanarayana Alleboina; Giridhar Mudduluru; Roy A Jensen; Joseph P McGuirk; Ramesh Balusu
Journal:  Mol Cancer Res       Date:  2018-11-28       Impact factor: 5.852

7.  Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation Process.

Authors:  Shigeo Ohba; Joydeep Mukherjee; Tor-Christian Johannessen; Andrew Mancini; Tracy T Chow; Matthew Wood; Lindsey Jones; Tali Mazor; Roxanne E Marshall; Pavithra Viswanath; Kyle M Walsh; Arie Perry; Robert J A Bell; Joanna J Phillips; Joseph F Costello; Sabrina M Ronen; Russell O Pieper
Journal:  Cancer Res       Date:  2016-10-06       Impact factor: 12.701

8.  p53 regulates Hsp90beta during arsenite-induced cytotoxicity in glutathione-deficient cells.

Authors:  Geetha M Habib
Journal:  Arch Biochem Biophys       Date:  2008-10-26       Impact factor: 4.013

Review 9.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

10.  Mutant p53 binds to estrogen receptor negative promoter via DNMT1 and HDAC1 in MDA-MB-468 breast cancer cells.

Authors:  Rita Arabsolghar; Tayebeh Azimi; Mozhgan Rasti
Journal:  Mol Biol Rep       Date:  2012-12-15       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.